
The selective zzso zzso zzso has been shown to be effective in preventing zzso and vomiting associated with highly zzso zzso zzso Two zzso zzso zzso studies zzso and zzso were undertaken to investigate the efficacy and safety of oral zzso in patients receiving zzso zzso regimens in the zzso zzso zzso patients undergoing their first cycle of zzso zzso or zzso 500 zzso chemotherapy were zzso to receive zzso or zzso 1, 4, or 8 zzso three times per day for 3 zzso In addition to zzso all patients received zzso methotrexate, or another zzso zzso zzso In study zzso zzso of zzso patients were zzso for zzso 297 of 324 patients in study zzso were zzso for zzso All patients in both studies were zzso for zzso All zzso groups were superior to zzso groups in both studies for all measured efficacy zzso In the two studies combined, zzso zzso zzso and zzso of patients in the zzso zzso zzso and zzso zzso groups, respectively, experienced no zzso zzso The rate of therapeutic failure was statistically lower in the zzso groups in both studies compared with the zzso zzso In addition, therapeutic failure decreased in a zzso zzso zzso of zzso food zzso time to first zzso episode, and need for rescue zzso were also improved for the zzso zzso When the patients were zzso for zzso regimens, those patients receiving zzso had a lower response rate with zzso and zzso than those on zzso zzso However, a zzso improvement in efficacy was still observed with zzso in this subset of zzso In patients receiving the more zzso high-dose zzso zzso or zzso 600 zzso regimens, a zzso improvement in efficacy also was zzso In conclusion, oral zzso was found to be an effective and safe zzso for patients receiving zzso chemotherapy in the zzso zzso The zzso dose was zzso particularly in patients receiving zzso or high-dose zzso zzso 

